Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
77,143,980
-
Total 13F shares
-
41,336,305
-
Share change
-
+8,216,120
-
Total reported value
-
$1,285,102,277
-
Price per share
-
$31.09
-
Number of holders
-
98
-
Value change
-
+$254,605,491
-
Number of buys
-
74
-
Number of sells
-
13
Institutional Holders of Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) as of Q1 2021
As of 31 Mar 2021 Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) had 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 41,336,305 shares of stock of the company.
Largest 10 holders included The Column Group LLC, TRV GP III, LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, BlackRock Inc., STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, and Bain Capital Life Sciences Investors, LLC.
This table shows 98 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.